Comparison of synthetic bone graft ABM/P-15 and allograft on uninstrumented posterior lumbar spine fusion in sheep.
ABM/P-15
Histology
Micro-CT
Posterolateral spinal fusion
Sheep
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
03 Jan 2019
03 Jan 2019
Historique:
received:
31
08
2018
accepted:
18
12
2018
entrez:
5
1
2019
pubmed:
5
1
2019
medline:
18
4
2019
Statut:
epublish
Résumé
Spinal fusion is a commonly used procedure in spinal surgery. To ensure stable fusion, bone graft materials are used. ABM/P-15 (commercial name i-Factor™ Flex) is an available synthetic bone graft material that has CE approval in Europe. This peptide has been shown to improve bone formation when used in devices with fixation or on bone defects. However, the lack of external stability and large graft size make posterolateral lumbar fusion (PLF) a most challenging grafting procedure. This prospective randomized study was designed to evaluate early spinal fusion rates using an anorganic bovine-derived hydroxyapatite matrix (ABM) combined with a synthetic 15 amino acid sequence (P-15)-ABM/P-15 bone graft, and compared with allograft in an uninstrumented PLF model in sheep. The objective of this study was to assess fusion rates when using ABM/P-15 in uninstrumented posterolateral fusion in sheep. Twelve Texas/Gotland mixed breed sheep underwent open PLF at 2 levels L2/L3 and L4/L5 without fixation instruments. The levels were randomized so that sheep received an ABM graft either with or without P15 coating. Sheep were euthanized after 4.5 months and levels were harvested and evaluated with a micro-CT scanner and qualitative histology. Fusion rates were assessed by 2D sections and 3D reconstruction images and fusion was defined as intertransverse bridging. There was 68% fusion rate in the allograft group and an extensive migration of graft material was noticed with a fusion rate of just 37% in the ABM/P-15 group. Qualitative histology showed positive osteointegration of the material and good correlation to scanning results. In this PLF fusion model, ABM/P15 demonstrated the ability to migrate when lacking external stability. Due to this migration, reported fusion rates were significantly lower than in the allograft group. The use of ABM/P15 as i-Factor™ Flex may be limited to devices with fixation and bone defects.
Sections du résumé
BACKGROUND
BACKGROUND
Spinal fusion is a commonly used procedure in spinal surgery. To ensure stable fusion, bone graft materials are used. ABM/P-15 (commercial name i-Factor™ Flex) is an available synthetic bone graft material that has CE approval in Europe. This peptide has been shown to improve bone formation when used in devices with fixation or on bone defects. However, the lack of external stability and large graft size make posterolateral lumbar fusion (PLF) a most challenging grafting procedure. This prospective randomized study was designed to evaluate early spinal fusion rates using an anorganic bovine-derived hydroxyapatite matrix (ABM) combined with a synthetic 15 amino acid sequence (P-15)-ABM/P-15 bone graft, and compared with allograft in an uninstrumented PLF model in sheep. The objective of this study was to assess fusion rates when using ABM/P-15 in uninstrumented posterolateral fusion in sheep.
METHODS
METHODS
Twelve Texas/Gotland mixed breed sheep underwent open PLF at 2 levels L2/L3 and L4/L5 without fixation instruments. The levels were randomized so that sheep received an ABM graft either with or without P15 coating. Sheep were euthanized after 4.5 months and levels were harvested and evaluated with a micro-CT scanner and qualitative histology. Fusion rates were assessed by 2D sections and 3D reconstruction images and fusion was defined as intertransverse bridging.
RESULTS
RESULTS
There was 68% fusion rate in the allograft group and an extensive migration of graft material was noticed with a fusion rate of just 37% in the ABM/P-15 group. Qualitative histology showed positive osteointegration of the material and good correlation to scanning results.
CONCLUSIONS
CONCLUSIONS
In this PLF fusion model, ABM/P15 demonstrated the ability to migrate when lacking external stability. Due to this migration, reported fusion rates were significantly lower than in the allograft group. The use of ABM/P15 as i-Factor™ Flex may be limited to devices with fixation and bone defects.
Identifiants
pubmed: 30606209
doi: 10.1186/s13018-018-1042-4
pii: 10.1186/s13018-018-1042-4
pmc: PMC6318885
doi:
Substances chimiques
Biocompatible Materials
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2Références
Tissue Eng. 1999 Feb;5(1):53-65
pubmed: 10207189
Biochem Biophys Res Commun. 2003 Nov 7;311(1):179-86
pubmed: 14575711
Tissue Eng. 2004 Jul-Aug;10(7-8):1148-59
pubmed: 15363171
Injury. 2005 Nov;36 Suppl 3:S20-7
pubmed: 16188545
Eur Cell Mater. 2007 Mar 02;13:1-10
pubmed: 17334975
Eur Spine J. 2009 Feb;18(2):244-53
pubmed: 19015899
Eur Spine J. 2010 Dec;19(12):2156-63
pubmed: 20694847
Spine (Phila Pa 1976). 2012 Jan 1;37(1):67-76
pubmed: 21311399
Bull Hosp Jt Dis (2013). 2013;71(1):39-48
pubmed: 24032582
Spine J. 2014 Sep 1;14(9):2019-27
pubmed: 24333459
J Neurosurg Spine. 2014 Jul;21(1):42-7
pubmed: 24980584
J Biomed Mater Res A. 2015 Apr;103(4):1357-65
pubmed: 25045068
J Am Acad Orthop Surg. 2014 Aug;22(8):503-11
pubmed: 25063748
J Neurosurg Spine. 2014 Dec;21(6):867-76
pubmed: 25325176
Orthopedics. 2014 Sep;37(9):e783-8
pubmed: 25350620
Int J Mol Sci. 2014 Dec 16;15(12):23359-76
pubmed: 25522168
Spine (Phila Pa 1976). 1989 Dec;14(12):1324-31
pubmed: 2617362
Biomed Res Int. 2015;2015:253858
pubmed: 26509146
Orthopedics. 2015 Dec;38(12):e1104-9
pubmed: 26652331
J Clin Neurosci. 2017 Oct;44:11-17
pubmed: 28676316
Eur Spine J. 2018 Aug;27(8):1868-1876
pubmed: 29546538
Global Spine J. 2018 Jun;8(4):396-412
pubmed: 29977726
Clin Orthop Relat Res. 1987 Dec;(225):7-16
pubmed: 3315383
Biomaterials. 1996 Jul;17(13):1345-50
pubmed: 8805984
J Biomed Mater Res. 1996 Aug;31(4):545-54
pubmed: 8836852
J Biomol Struct Dyn. 1997 Apr;14(5):547-60
pubmed: 9130077
Spine (Phila Pa 1976). 1997 Dec 15;22(24):2813-22
pubmed: 9431617